Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724412 | SCV000228542 | uncertain significance | not provided | 2014-12-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001088000 | SCV000643732 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-12-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000176811 | SCV000729566 | likely benign | not specified | 2017-12-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV002345610 | SCV002640811 | likely benign | Cardiovascular phenotype | 2020-04-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003150051 | SCV003838545 | likely benign | Cardiomyopathy | 2021-10-13 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000176811 | SCV004122656 | likely benign | not specified | 2023-10-09 | criteria provided, single submitter | clinical testing |